| 摘要 |
(57) The present invention relates to the use of calcium antagonists, combinations of two or more different calcium antagonists, or combinations of calcium antagonists and zinc salts for protecting warm blooded animals against deleterious effects of radiation, to the use for the manufacture of radioprotective pharmaceutical preparations, and to novel synergistic radioprotective pharmaceutical preparations. A representative example of calcium antagonist is dilliazem.
|
